ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Uni of Manchester partners with AVROBIO for Hunter syndrome gene therapy
October 10, 2020The University of Manchester in the UK has partnered with US-based biotech AVROBIO on the clinical development of an investigational gene therapy for mucopolysaccharidosis type II (MPS II), or Hunter syndrome. -
Magenta, AVROBIO to evaluate antibody drug conjugate MGTA-117
May 08, 2020Magenta Therapeutics has signed an agreement with AVROBIO to evaluate the potential utility of its novel targeted antibody-drug conjugate (ADC) MGTA-117 as a potential conditioning regimen for lentiviral gene therapies. -
Avrobio and Magenta Therapeutics Collaborate
May 07, 2020Evaluate targeted antibody-drug conjugate as a potential conditioning regimen for lentiviral gene therapies.
Pharma Sources Insight January 2025
